WuXi Biologics (Cayman) Inc.
(Incorporated in the Cayman Islands with limited liability)

Press Releases       

2019-August-19	WuXi Biologics Reports Outstanding Interim Results 52.4% Year-on-Year Revenue Growth to RMB1,607.1 Million Net Profit Increased 80.1% Year-on-Year to RMB449.5 Million Gross Profit Margin, Net Profit Margin and Adjusted Net Profit Margin All Record High Total Backlog Surged to US$4.6 Billion (in PDF)
2019-March-20	WuXi Biologics Receives EMA GMP Certificates (in PDF)
2019-March-18	WuXi Biologics Continues to Deliver Record Results, 56.6% Year-on-Year Revenue Growth to RMB2,534.5 Million Net Profit 249.6% of Same Period Last Year to MB630.5 Million, Adjusted Net Profit 173.6% of Same Period Last Year to RMB751.5 Million, Total Backlog Surged 146.2% to US$3.6 Billion (in PDF)
2019-January-16	Press Release (Chinese Version) (in PDF)
2022	2022 Press Releases
2021	2021 Press Releases
2020	2020 Press Releases
2018	2018 Press Releases
2017	2017 Press Releases